Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PAK4 |
| Upstream (Parents) |
|---|
| (<<) ANKDD1A → PAK4 |
| (<<) ATP2A2 → PAK4 |
| (<<) ERBB2 → PAK4 |
| (<<) GSK3A → PAK4 |
| (<<) JUND → PAK4 |
| (<<) MAP3K10 → PAK4 |
| (<<) MAPK3 → PAK4 |
| (<<) NRSN2 → PAK4 |
| (<<) PLD3 → PAK4 |
| (<<) PRKCD → PAK4 |
| (<<) RARG → PAK4 |
| (<<) RAVER1 → PAK4 |
| (<<) RPS16 → PAK4 |
| (<<) SH3GLB2 → PAK4 |
| (<<) TUBB2C → PAK4 |
| Downstream (Children) |
|---|
| PAK4 → ACTN4 (>>) |
| PAK4 → ADAM15 (>>) |
| PAK4 → AKT3 (>>) |
| PAK4 → ALDOA (>>) |
| PAK4 → ANKRD27 (>>) |
| PAK4 → CAMKK1 (>>) |
| PAK4 → CD83 (>>) |
| PAK4 → CISH (>>) |
| PAK4 → CNFN (>>) |
| PAK4 → CXCL1 (>>) |
| PAK4 → CYP2U1 (>>) |
| PAK4 → DLGAP3 (>>) |
| PAK4 → DMPK (>>) |
| PAK4 → GNG10 (>>) |
| PAK4 → HDAC9 (>>) |
| PAK4 → HPCAL1 (>>) |
| PAK4 → HRAS (>>) |
| PAK4 → ITGA6 (>>) |
| PAK4 → LIG1 (>>) |
| PAK4 → LOC642031 (>>) |
| PAK4 → LYPLA2 (>>) |
| PAK4 → MAP3K8 (>>) |
| PAK4 → MTMR6 (>>) |
| PAK4 → NCOA7 (>>) |
| PAK4 → NFKBIB (>>) |
| PAK4 → PDK2 (>>) |
| PAK4 → PLCD1 (>>) |
| PAK4 → PRKCSH (>>) |
| PAK4 → PRR7 (>>) |
| PAK4 → PRSS22 (>>) |
| PAK4 → RHOQ (>>) |
| PAK4 → RHOT1 (>>) |
| PAK4 → ROCK1 (>>) |
| PAK4 → RPL22L1 (>>) |
| PAK4 → RXRA (>>) |
| PAK4 → ST3GAL6 (>>) |
| PAK4 → TMEFF2 (>>) |
| PAK4 → VPS37B (>>) |
| PAK4 → WDR36 (>>) |
| PAK4 → ZNF467 (>>) |
